FDA Import Refusal AEK-9274982-7/20003/1 — GLAXO SMITHKLINE LTD
The FDA refused shipment AEK-9274982-7/20003/1 from GLAXO SMITHKLINE LTD (India) on Feb 10, 2026. The refused product falls under Drugs and Biologics — AMIKACIN SULFATE (AMINOGLYCOSIDES). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Feb 10, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56DDY06 AMIKACIN SULFATE (AMINOGLYCOSIDES)
- Charges
- 75